These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 8376405
1. Type IIB mutation His-505-->Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib. Rabinowitz I, Randi AM, Shindler KS, Tuley EA, Rustagi PK, Sadler JE. J Biol Chem; 1993 Sep 25; 268(27):20497-501. PubMed ID: 8376405 [Abstract] [Full Text] [Related]
2. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets. Hillery CA, Mancuso DJ, Evan Sadler J, Ponder JW, Jozwiak MA, Christopherson PA, Cox Gill J, Paul Scott J, Montgomery RR. Blood; 1998 Mar 01; 91(5):1572-81. PubMed ID: 9473222 [Abstract] [Full Text] [Related]
3. Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets. Kroner PA, Kluessendorf ML, Scott JP, Montgomery RR. Blood; 1992 Apr 15; 79(8):2048-55. PubMed ID: 1373334 [Abstract] [Full Text] [Related]
4. Characterization of recombinant von Willebrand factor corresponding to mutations in type IIA and type IIB von Willebrand disease. Ribba AS, Voorberg J, Meyer D, Pannekoek H, Pietu G. J Biol Chem; 1992 Nov 15; 267(32):23209-15. PubMed ID: 1429668 [Abstract] [Full Text] [Related]
5. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib. Rabinowitz I, Tuley EA, Mancuso DJ, Randi AM, Firkin BG, Howard MA, Sadler JE. Proc Natl Acad Sci U S A; 1992 Oct 15; 89(20):9846-9. PubMed ID: 1409710 [Abstract] [Full Text] [Related]
6. Recombinant von Willebrand factor Arg578-->Gln. A type IIB von Willebrand disease mutation affects binding to glycoprotein Ib but not to collagen or heparin. Randi AM, Jorieux S, Tuley EA, Mazurier C, Sadler JE. J Biol Chem; 1992 Oct 15; 267(29):21187-92. PubMed ID: 1400429 [Abstract] [Full Text] [Related]
7. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor. Inbal A, Kornbrot N, Harrison P, Randi AM, Sadler JE. Thromb Haemost; 1993 Dec 20; 70(6):1058-62. PubMed ID: 8165601 [Abstract] [Full Text] [Related]
17. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor. Hilbert L, Jenkins PV, Gaucher C, Meriane E, Collins PW, Pasi KJ, Mazurier C. Thromb Haemost; 2000 Aug 20; 84(2):188-94. PubMed ID: 10959688 [Abstract] [Full Text] [Related]
18. The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor. Ribba AN, Hilbert L, Lavergne JM, Fressinaud E, Boyer-Neumann C, Ternisien C, Juhan-Vague I, Goudemand J, Girma J, Mazurier C, Meyer D. Blood; 2001 Feb 15; 97(4):952-9. PubMed ID: 11159522 [Abstract] [Full Text] [Related]
19. Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease. Ribba AS, Christophe O, Derlon A, Cherel G, Siguret V, Lavergne JM, Girma JP, Meyer D, Pietu G. Blood; 1994 Feb 01; 83(3):833-41. PubMed ID: 8298143 [Abstract] [Full Text] [Related]
20. Leu 697-->Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease. Hilbert L, Gaucher C, de Romeuf C, Horellou MH, Vink T, Mazurier C. Blood; 1994 Mar 15; 83(6):1542-50. PubMed ID: 8123843 [Abstract] [Full Text] [Related] Page: [Next] [New Search]